True Leaf to Present at 7th Annual MicroCap Conference in New York City
April 04, 2018 07:00 ET
|
True Leaf Medicine International Ltd.
VERNON, British Columbia, April 04, 2018 (GLOBE NEWSWIRE) -- True Leaf Medicine International Ltd. (“True Leaf”) (CSE:MJ) (FSE:TLA) (OTCQB:TRLFF), the quality of life cannabis company for people and...
True Leaf Announces Appointment of Chief Scientific Officer and Medical Advisory Board
March 27, 2018 07:00 ET
|
True Leaf Medicine International Ltd.
VERNON, British Columbia, March 27, 2018 (GLOBE NEWSWIRE) -- True Leaf Medicine International Ltd. (“True Leaf”) (CSE:MJ) (FSE:TLA) (OTCQB:TRLFF), the quality of life cannabis company for people and...
True Leaf Announces Cannabis Cultivation Team
March 19, 2018 07:00 ET
|
True Leaf Medicine International Ltd.
VERNON, British Columbia, March 19, 2018 (GLOBE NEWSWIRE) -- True Leaf Medicine International Ltd. (“True Leaf”) (CSE:MJ) (FSE:TLA) (OTCQB:TRLFF), the quality of life cannabis company for people and...
True Leaf Breaks Ground on North Okanagan Cannabis Production Facility
March 02, 2018 18:07 ET
|
True Leaf Medicine International Ltd.
VERNON, British Columbia, March 02, 2018 (GLOBE NEWSWIRE) -- True Leaf Medicine International Ltd. (“True Leaf”) (CSE:MJ) (FSE:TLA) (OTCQB:TRLFF), the quality of life cannabis company for people and...
BELGRAVIA CAPITAL INTERNATIONAL and Fanlogic Commence Design of Blockchain Loyalty Program for the Global Cannabis Industry
January 25, 2018 07:00 ET
|
Belgravia Capital International
TORONTO, Jan. 25, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announce the execution of...
BELGRAVIA CAPITAL INTERNATIONAL receives cash payment, appoints renowned Dermatologist as special advisor to ICP Organics, and provides updates on additional blockchain developments
January 10, 2018 07:00 ET
|
Belgravia Capital International
TORONTO, Jan. 10, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announced that the second...
NeutriSci Announces a Major R&D MOU With Scientus Pharma to Develop a Medical Cannabinoid Retail Product
January 08, 2018 08:30 ET
|
NeutriSci International Inc.
VANCOUVER, British Columbia, Jan. 08, 2018 (GLOBE NEWSWIRE) -- NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9), the innovator and pioneer behind...
BELGRAVIA CAPITAL INTERNATIONAL announces LOI with R&D Pharma Corp.
January 04, 2018 07:00 ET
|
Belgravia Capital International
TORONTO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announce the execution of...
Sunniva Inc. Files Preliminary Prospectus
September 26, 2017 17:18 ET
|
Sunniva Inc.
CALGARY, Alberta, Sept. 26, 2017 (GLOBE NEWSWIRE) -- Sunniva Inc. ("Sunniva" or "the Company"), a North American provider of medical cannabis products and services, has filed its preliminary...
AXIM® Biotech Expands Advisory Board With Oncology Specialist and Medicinal Cannabis Leading Expert – Dr. Donald Abrams
May 09, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, May 09, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced the addition to its...